PT  - JOURNAL ARTICLE
ED  - Connolly, Stuart
TI  - ACTIVE-W Discontinued-Oral Anticoagulants Remain Treatment of Choice in Atrial Fibrillation
DP  - 2005  01
TA  - MD Conference Express
PG  - 15--15
VI  - 5
IP  - 1
4099  - http://mdc.sagepub.com/content/5/1/15.1.short
4100  - http://mdc.sagepub.com/content/5/1/15.1.full
AB  - ACTIVE-W—one study under the larger umbrella of the ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Trial—was discontinued in September 2005 after an excess risk of vascular events was observed in participants receiving clopidogrel plus aspirin compared with those receiving warfarin.